Fibrinogen Usage and Forecast Globally to 2032
Announcement
A new and expanded fibrinogen forecast report has recently been completed and is immediately available called:
THE WORLDWIDE FIBRINOGEN MARKET:
PRESENT SITUATION AND FORECAST TO 2032
This report updates and expands a previous report on the topic published in 2021, with much more detail on the US acquired fibrinogen deficiency by indication.
Fibrinogen as an intravenous purified plasma product has two markets: a small congenital deficiency replacement market and a much larger acquired fibrinogen deficiency market for patients with massive hemorrhage. Marketing Research Bureau surveys have identified fibrinogen as among the most promising therapeutic proteins, reflected also in impressive recent sales growth.
This new report identifies intravenous fibrinogen usage from over 70 countries in 2025 based on actual usage data in markets surveyed by the MRB. Interviews with over a almost 20 physicians, fractionators and industry experts on the usage and trends of intravenous fibrinogen usage have enabled the MRB to develop a market forecast of the global fibrinogen market through the year 2032.
For 2026 through 2032, the report forecasts country-level fibrinogen sales in units, sales and pricing. Also identified are key fibrinogen growth drivers in countries in the major markets in Europe, North America, and China.
The report is delivered as a pdf file and the supporting Excel files. The current report table of contents is shown below to help the reader understand the value of the report. The report is immediately available.
The Worldwide Fibrinogen Market
EXECUTIVE SUMMARY
1) Overview of Fibrinogen and Use
1.1) Coagulation Cascade and Role of Fibrinogen
1.2) Fibrinogen Deficiency and Treatment
Congenital Fibrinogen Deficiency
Acquired Fibrinogen Deficiency
1.3) Standard of Care in Severe Hemorrhage Situations
Standard of Care Methods of Testing Hemostasis and Coagulopathy
Countries that Monitor Fibrinogen Levels have Higher Fibrinogen Sales
Competition to Fibrinogen
2) Fibrinogen Products and Pipeline
2.1) Product Currently Available
2.2) Fibrinogen concentrate Pipeline
3) Forecast Assumptions
4) Fibrinogen Usage & Forecast in Europe
4.1) 2025 Fibrinogen Usage in Europe
Treatment Trends in Austria, Germany & Switzerland and Why it Leads to High Fibrinogen Usage
Treatment Trends in Countries with Moderate Fibrinogen Usage Per Capita
Treatment Trends in Countries with Low Fibrinogen Usage Per Capita
4.2) Forecast to 2032 in Europe
Forecast trends in High-Use Countries Austria, Germany & Switzerland
Forecast trends in Medium-Use Countries in Europe
Forecast trends in Low-Use Countries in Europe
5) Fibrinogen Usage & Forecast in North America
5.1) 2025 Fibrinogen Usage in North America
United States Today
Current Fibrinogen usage by indication in the US
Canada Today
5.2) Forecast to 2032 in North America
United States Forecast Trends
Forecast of fibrinogen usage by indication in the US
IFC Forecat trends in the US
Fibrinogen vs. IFC vs. Cryoprecipitate share in 2025 through 2032
Canada Forecast Trends
6) Fibrinogen Usage & Forecast in Asia & Pacific
6.1) 2025 Fibrinogen Usage in Asia & Pacific
China Today
Other Countries in Asia & Pacific
6.2) Forecast to 2032 in Asia & Pacific
China Forecast Trends
Other Countries in Asia & Pacific Forecast Trends
7) Fibrinogen Usage & Forecast in Middle East & Africa
7.1) 2025 Fibrinogen Usage in Middle East & Africa
7.2) Forecast to 2032 in Middle East & Africa
8) Fibrinogen Usage & Forecast in Latin America
8.1) 2025 Fibrinogen Usage in Latin America
8.2) Forecast to 2032 in Latin America
9) Worldwide Usage and Forecast of Fibrinogen Usage
9.1) 2025 Worldwide Fibrinogen Usage
9.2) Worldwide Forecast to 2032
Role of Acquired Fibrinogen Deficiency Uptake